Author:
Almond Lisa M.,Hoggard Patrick G.,Edirisinghe Damitha,Khoo Saye H.,Back David J.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference27 articles.
1. Palella FJ, Jr, Deloria-Knoll M, Chmiel JS et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med2003; 138: 620–6.
2. Marzolini C, Telenti A, Decosterd LA et al. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. Aids2001; 15: 71–5.
3. Rotger M, Colombo S, Furrer H et al. Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenet Genomics2005; 15: 1–5.
4. Chaillou S, Durant J, Garraffo R et al. Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir. HIV Clin Trials2002; 3: 493–501.
5. Colombo S, Telenti A, Guignard N et al. Differences in intracellular plasma concentration ratio and intracellular drug accumulation between PIs and NNRTIs. In: 5th International Workshop on Clinical Pharmacology of HIV Therapy, Rome2004; Abstract 52.
Cited by
95 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献